Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 6, 2023
Osteosarcomas With Few Chromosomal Alterations or Adult Onset Are Genetically HeterogeneousValeria Difilippo, Karim H Saba, Emelie Styring, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 14, 2012
FOSL1 as a candidate target gene for 11q12 rearrangements in desmoplastic fibroblastomaGemma Macchia, Domenico Trombetta, Emely Möller, et al.
Cancer Genetics|November 27, 2012
SNP array and FISH findings in two pleomorphic hyalinizing angiectatic tumorsArezoo Mohajeri, Lars-Gunnar Kindblom, Vaiyapuri P Sumathi, et al.
Human Molecular Genetics|September 28, 2013
Integrative genome and transcriptome analyses reveal two distinct types of ring chromosome in soft tissue sarcomasKarolin H Nord, Gemma Macchia, Johnbosco Tayebwa, et al.
The Journal of Pathology. Clinical Research|February 6, 2020
NTRK fusions in osteosarcoma are rare and non-functional eventsBaptiste Ameline, Karim H Saba, Michal Kovac, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2010
Concomitant deletions of tumor suppressor genes MEN1 and AIP are essential for the pathogenesis of the brown fat tumor hibernomaKarolin H Nord, Linda Magnusson, Margareth Isaksson, et al.
Genes, Chromosomes & Cancer|May 9, 2019
Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusionKarim H Saba, Louise Cornmark, Marianne Rissler, et al.
Cancer Genetics|November 14, 2012
Homozygous deletions of cadherin genes in chondrosarcoma-an array comparative genomic hybridization studyTarja Niini, Ilari Scheinin, Leo Lahti, et al.
The American Journal of Surgical Pathology|January 21, 2014
Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcomaElsa Arbajian, Florian Puls, Linda Magnusson, et al.
Plos One|November 16, 2013
Recurrent chromosome 22 deletions in osteoblastoma affect inhibitors of the Wnt/beta-catenin signaling pathwayKarolin H Nord, Jenny Nilsson, Elsa Arbajian, et al.
Pageof 4